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Novel strategy for generation of mucosal immune responses 
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A significant hurdle in effective vaccine design for infec-
tious pathogens is the ability to mount immune responses
at the portal of entry, namely mucosal sites. The develop-
ment of a systemic-delivered vaccine approach driving
secretory IgA and mucosal T cell immune responses
against pathogens would fundamentally change many
vaccine strategies. Using mucosal pathogens HIV-1 and
Influenza A as models, we demonstrate that a novel sys-
temic administered DNA vaccination strategy utilizing co-
delivery of specific mucosal-derived chemokine adju-
vants, can produce distal mucosal immune responses.
This strategy resulted in redirection of a4b7 and CCR9 or
CCR10 positive immune cells to the site of immunization
with mucosal retrafficking phenotype. The immune phe-
notype included enhanced cytokine and cytolytic markers
expressed by antigen-specific T cells from the spleen, lung
and lamina propria, as well as elevated IgG and secretory
IgA responses in secondary lymphoid organs, B cells from
the gut, peripheral blood and fecal extracts. Systemic
immunization controls, as expected, failed to induce
mucosal immunity. These studies have great significance
for basic understanding of gut lymphocyte homing,
mucosal phenotype commitment and development of
vaccine strategies for mucosal pathogens. This work is
supported by F32AI054152 to MAK, and N01-A1-15429,
NIAID-HVDDT to DBW.
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